Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

American Stroke Association unveils guidelines that could prevent up to 80% of strokes through eight essential lifestyle ...

Researchers at the University of Maryland identified a potential link between early-onset ischemic stroke and a genetic ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Renn Asia Wellness, a Malaysian holistic healthcare centre, is offering complementary ways to tackle stroke care and ...

A report has warned that stroke victims are facing a postcode lottery to access lifesaving treatment. The Stroke Association ...

Thanks to a pioneering genetic testing pilot at Doncaster and Bassetlaw Teaching Hospitals (DBTH), 130 stroke patients have ...

Blood Test May Detect Stroke Type Before Hospital Arrival, Allowing Faster Treatment Jan. 30, 2025 — People with brain bleeds had nearly 7 times higher blood levels of a specific brain protein ...